Table 3 Causes of death in the hepatitis C group with abnormal transaminase levels
From: Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients
IFN treated Group A (n = 152) | SVR Group A1 (n = 72) | Non-SVR Group A2 (n = 80) | No treated Group B (n = 199) | |
|---|---|---|---|---|
Total deaths | 25 | 9 | 16 | 90 |
Unknown cause | 0 | 0 | 0 | 1 |
Liver-related | 6 (24.0%) | 1 (11.1%) | 5 (31.2%) | 32 (36.0%) |
Others | 19 (76.0%) | 8 (88.9%) | 11 (68.8%) | 57 (64.0%) |